Cinnarizine/dimenhydrinate

From Wikipedia, the free encyclopedia

Cinnarizine/dimenhydrinate
Combination of
CinnarizineAntihistamine and calcium channel blocker
DimenhydrinateAntihistamine and antiemetic
Clinical data
Trade namesCizigo, Cizinate, Cizere
Pregnancy
category
Routes of
administration
By mouth
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only) [1]
Identifiers
CAS Number
UNII

Cinnarizine/dimenhydrinate, sold under the brand name Cizinate among others is a fixed-dose combination medication for the treatment of vertigo in adults.[1] It contains cinnarizine and dimenhydrinate.[1] It is taken by mouth.[1]

It was approved for medical use in Australia in December 2018.[1]

References[edit]

  1. ^ a b c d e f "Cizinate ARTG ID 288566". TGA eBS. Retrieved 23 July 2020.

Further reading[edit]

External links[edit]

  • "Cinnarizine". Drug Information Portal. U.S. National Library of Medicine.
  • "Dimenhydrinate". Drug Information Portal. U.S. National Library of Medicine.